Freenome Inc, based in South San Francisco, CA, is a pioneering company focused on early cancer detection through the development of next-generation blood tests. Their multiomics platform combines molecular biology and machine learning to identify cancer-associated patterns among billions of circulating biomarkers from tumor and non-tumor-derived sources.
With a mission to move early cancer detection forward, Freenome is dedicated to developing accessible tests that can detect cancer in its earliest and most treatable stages. Their blood tests, tailored to different types of cancer, analyze biomarkers from both tumor and non-tumor-derived sources to detect the body's earliest warning signs of cancer.
Generated from the website